FDA Approves First Self-Collection Kit for Cervical Cancer Screening, Allowing At-Home Sample Collection

The Food and Drug Administration (FDA) has approved the first self-collection kit for cervical cancer screening. Women can now collect their own cervical samples at home and then send them to a designated laboratory for testing. This new development provides an alternative to traditional Pap smears performed in a doctor’s office. The FDA approval marks the first time a self-sampling option has become available for cervical cancer screening. After collecting their sample, women will mail the kit to a laboratory for analysis.

Newsflash | Powered by GeneOnline AI
Date: May 9, 2025

Related posts:

Global Underuse of Cardiovascular Disease Medications Calls for Enhanced Strategies New Skin Disease Identified Through Advanced Diagnostic Technology Study Finds Ignoring One’s Better Judgment Amplifies Regret and Self-Blame Study Reveals How ‘Two-Hit Stress’ During Pregnancy Impacts Brain and Behavior in Mice

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後